These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging-radioguided occult lesion localization (ROLL) in breast cancer using Tc-99m macro-aggregated albumin and distilled water control. Philadelpho Arantes Pereira F; Martins G; Gregorio Calas MJ; Fonseca Torres de Oliveira MV; Gasparetto EL; Barbosa da Fonseca LM BMC Med Imaging; 2013 Sep; 13():33. PubMed ID: 24044428 [TBL] [Abstract][Full Text] [Related]
5. Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma. Dinnes J; Ferrante di Ruffano L; Takwoingi Y; Cheung ST; Nathan P; Matin RN; Chuchu N; Chan SA; Durack A; Bayliss SE; Gulati A; Patel L; Davenport C; Godfrey K; Subesinghe M; Traill Z; Deeks JJ; Williams HC; Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012806. PubMed ID: 31260100 [TBL] [Abstract][Full Text] [Related]
6. [Clinical application of ROLL technique in non-breast diseases. Complementary use after PET-CT study]. Infante JR; Rayo JI; Serrano J; Domínguez ML; García L; Durán C; Moreno M Rev Esp Med Nucl Imagen Mol; 2015; 34(3):162-6. PubMed ID: 25304844 [TBL] [Abstract][Full Text] [Related]
7. Hybrid radioguided occult lesion localization (hybrid ROLL) of (18)F-FDG-avid lesions using the hybrid tracer indocyanine green-(99m)Tc-nanocolloid. KleinJan GH; Brouwer OR; Mathéron HM; Rietbergen DD; Valdés Olmos RA; Wouters MW; van den Berg NS; van Leeuwen FW Rev Esp Med Nucl Imagen Mol; 2016; 35(5):292-7. PubMed ID: 27174865 [TBL] [Abstract][Full Text] [Related]
8. Staging of regional lymph nodes in melanoma patients by means of 99mTc-MIBI scintigraphy. Alonso O; Martínez M; Delgado L; De León A; De Boni D; Lago G; Garcés M; Fontes F; Espasandín J; Priario J J Nucl Med; 2003 Oct; 44(10):1561-5. PubMed ID: 14530467 [TBL] [Abstract][Full Text] [Related]
9. Radio-Guided Occult Lesion Localization With 99m Tc for the Localization of Nonpalpable Melanoma and Soft Tissue Sarcoma Lesions: A Feasibility Study. Reijers SJM; Mook FJ; Groen HC; Schrage Y; Stokkel MPM; Donswijk ML; van Houdt WJ Clin Nucl Med; 2024 Jan; 49(1):23-26. PubMed ID: 37991434 [TBL] [Abstract][Full Text] [Related]
10. Radioguided sentinel lymph node biopsy in patients with malignant cutaneous melanoma: the nuclear medicine contribution. Mariani G; Erba P; Manca G; Villa G; Gipponi M; Boni G; Buffoni F; Suriano S; Castagnola F; Bartolomei M; Strauss HW J Surg Oncol; 2004 Mar; 85(3):141-51. PubMed ID: 14991886 [TBL] [Abstract][Full Text] [Related]
11. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions. Serban ED; Farnetani F; Pellacani G; Constantin MM Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304 [TBL] [Abstract][Full Text] [Related]
12. Maurer T; Robu S; Schottelius M; Schwamborn K; Rauscher I; van den Berg NS; van Leeuwen FWB; Haller B; Horn T; Heck MM; Gschwend JE; Schwaiger M; Wester HJ; Eiber M Eur Urol; 2019 Apr; 75(4):659-666. PubMed ID: 29625755 [TBL] [Abstract][Full Text] [Related]
13. Multimodality approach of perioperative 18F-FDG PET/CT imaging, intraoperative 18F-FDG handheld gamma probe detection, and intraoperative ultrasound for tumor localization and verification of resection of all sites of hypermetabolic activity in a case of occult recurrent metastatic melanoma. Povoski SP; Hall NC; Martin EW; Walker MJ World J Surg Oncol; 2008 Jan; 6():1. PubMed ID: 18186915 [TBL] [Abstract][Full Text] [Related]
14. Clinical and Prognostic Value of Albano D; Familiari D; Fornito MC; Scalisi S; Laudicella R; Galia M; Grassedonio E; Ruggeri A; Ganduscio G; Messina M; Spada M; Midiri M; Alongi P Curr Radiopharm; 2020; 13(1):42-47. PubMed ID: 31595860 [TBL] [Abstract][Full Text] [Related]
15. Sentinel node biopsy in clinical stage 1 melanoma: rationale for restaging and follow-up. Mazzuca N; Bagnoni G; Solimeo C; Malvaldi F; Pratali R; Ceccarini M; Santini P; Morini V Tumori; 2000; 86(4):351-3. PubMed ID: 11016727 [TBL] [Abstract][Full Text] [Related]
16. Sentinel node biopsy in patients with cutaneous melanoma. Cafiero F; Peressini A; Gipponi M; Rainero ML; Villa G; Sertoli MR; Bertoglio S; Moresco L Semin Surg Oncol; 1998 Dec; 15(4):284-6. PubMed ID: 9829388 [TBL] [Abstract][Full Text] [Related]
17. Sentinel node biopsy for melanoma: a study of 241 patients. Chakera AH; Drzewiecki KT; Eigtved A; Juhl BR Melanoma Res; 2004 Dec; 14(6):521-6. PubMed ID: 15577324 [TBL] [Abstract][Full Text] [Related]
18. Use of low-dose technetium Tc 99m sulfur colloid to locate sentinel lymph nodes in melanoma of the head and neck: preliminary study. Rasgon BM Laryngoscope; 2001 Aug; 111(8):1366-72. PubMed ID: 11568570 [TBL] [Abstract][Full Text] [Related]
19. The utility of PET-CT in the staging and management of advanced and recurrent malignant melanoma. Twycross SH; Burger H; Holness J S Afr J Surg; 2019 Sep; 57(3):44-49. PubMed ID: 31392864 [TBL] [Abstract][Full Text] [Related]